A Globaltech patent for mining survey tools is facing another test, with rival technology company Reflex Technologies lodging an appeal after its invalidity challenge flopped.
Technology company Reflex Instruments has lost its challenge to rival Globaltech’s patent for two mining survey tools, with a judge finding Reflex had not established the technology wasn’t novel and lacked an inventive step.
A judge has found that Uniden infringed rival GME’s design patent for a handheld radio, derailing the company’s plan for an Australian launch of two products.
A judge has questioned GME’s pursuit of additional damages in its intellectual property lawsuit against Japan’s Uniden that alleges the upcoming launch by the wireless communication giant of two new CB radio products amounts to infringement of its design patent.
Japan’s Uniden has been hit with an intellectual property lawsuit by Australia’s only CB radio manufacturer, which alleges the upcoming launch by the wireless communications giant of two new products amounts to infringement of its design patent.
Global mine technology company Minetek has lost its bid to access USB devices held by equipment manufacturer Howden’s solicitors for use in a potential lawsuit against a former employee who it says may have unlawfully used confidential company information.
Global mine technology company Minetek is considering a lawsuit against a former employee who may have unlawfully used confidential company information, a court has heard.
A judge has thrown out trade mark infringement claims brought by AGL against Greenpeace for using the energy company’s logo in a public campaign labelling it “Australia’s biggest climate polluter”.
Building and construction information service provider BCI Media is suing CoreLogic, accusing the property data analytics company of unauthorised access and scraping confidential information from its copyright-protected leads platform.
The High Court will decide whether the Full Court was wrong to overturn a $26.3 million judgment for Danish drug maker H Lundbeck in its long-running patent battle with generic drug maker Sandoz over the patent for blockbuster antidepressant Lexapro.